The Machine Learning in Drug Discovery Symposium was held on November 7, 2025.
This hybrid symposium highlights recent progress in the application of machine learning techniques to drug discovery and brings together researchers working in applying machine learning to target validation, hit identification and optimization, clinical trial design, biologics, and other areas of drug discovery for talks, poster sessions and networking.
For questions about the symposium or interest in sponsoring a future symposium, reach out to mlinddsymposium@broadinstitute.org.
Keynote speaker
Tom Miller
Co-founder and Chief Executive Officer
Iambic Therapeutics
Sponsors
Platinum
Gold
Silver
